TBPH
Theravance Biopharma Inc.
Company Overview
| Mkt Cap | $710.09M | Price | $14.66 |
| Volume | 393.27K | Change | +2.52% |
| P/E Ratio | -12.6 | Open | $14.31 |
| Revenue | $64.4M | Prev Close | $14.30 |
| Net Income | $-56.4M | 52W Range | $7.90 - $15.15 |
| Div Yield | N/A | Target | $20.00 |
| Overall | 64 | Value | 60 |
| Quality | 44 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyTheravance Biopharma Inc. (TBPH) is a leading Healthcare company in the Biotechnology industry, currently trading at $14.66 with a market capitalization of $710.09 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows TBPH with a volume of 393K shares. The stock opened up 0.07% from yesterday's close of $14.30. Current analyst estimates project earnings of $-0.46 per share for this year, with next year targeting $-0.69.
TBPH demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including COLL, CORT, CPRX, CTLT.
Key investment considerations for TBPH include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 36.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TBPH | $14.66 | +2.5% | 393.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Theravance Biopharma Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW